BRANCHED-CHAIN FATTY-ACIDS PRODUCED BY MUTANTS OF STREPTOMYCES-FRADIAE, PUTATIVE PRECURSORS OF THE LACTONE RING OF TYLOSIN

被引:25
作者
HUBER, MLB [1 ]
PASCHAL, JW [1 ]
LEEDS, JP [1 ]
KIRST, HA [1 ]
WIND, JA [1 ]
MILLER, FD [1 ]
TURNER, JR [1 ]
机构
[1] ELI LILLY INT CORP,LILLY RES LAB,INDIANAPOLIS,IN 46285
关键词
D O I
10.1128/AAC.34.8.1535
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Three branched-chain fatty acids (7-hydroxy-4,6-dimethylnona-2,4-dienoic acid [compound 1], its 7-epimer [compound 2], and 7-keto-4,5-dimethylnona-2,4-dienoic acid [compound 3]) and a ketone (9-hydroxy-6,8-dimethylundeca-4,6-dien-3-one [compound 4]) were isolated from the culture broth of mutants of Streptomyces fradiae which were blocked in the biosynthesis of the macrolide antibiotic tylosin. Two phenotypic classes of mutants of this organism which were blocked in the addition of mycaminose to tylactone (compound 6) accumulated these compounds. These compounds were not produced by mutants which were blocked in lactone synthesis, in steps beyond mycaminose addition, or by the wild-type strain. Synthesis of these compounds, like synthesis of tylosin, was inhibited by the addition of cerulenin. Compounds 1, 2, and 3 were partially interconvertible by these mutants; but they were not produced from the degradation of tylactone and they were not directly incorporated into tylosin by intact cells. The structures of compounds 1 and 2 were equivalent to that of a predicted intermediate (S. Yue, J.S. Duncan, Y. Yamamoto, and C.R. Hutchinson, J. Am. Chem. Soc. 109: 1253-1255, 1987) in the biosynthesis of tylactone. The ketone (compound 4) reported previously (N.D. Jones, M.O. Chaney, H.A. Kirst, G.M. Wild, R.H. Baltz, R.L. Hamill, and J.W. Paschal, J. Antibiot. 35: 420-425, 1982) appears to be the decarboxylation product of the intermediate following that represented by compound 1. This represents the first report of the isolation of putative precursors of tylactone from tylosin-producing organisms.
引用
收藏
页码:1535 / 1541
页数:7
相关论文
共 27 条
  • [1] BALTZ R H, 1981, Microbiology (Washington D C), P371
  • [2] PROPERTIES OF STREPTOMYCES-FRADIAE MUTANTS BLOCKED IN BIOSYNTHESIS OF THE MACROLIDE ANTIBIOTIC TYLOSIN
    BALTZ, RH
    SENO, ET
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (02) : 214 - 225
  • [3] BIOSYNTHESIS OF THE MACROLIDE ANTIBIOTIC TYLOSIN - A PREFERRED PATHWAY FROM TYLACTONE TO TYLOSIN
    BALTZ, RH
    SENO, ET
    STONESIFER, J
    WILD, GM
    [J]. JOURNAL OF ANTIBIOTICS, 1983, 36 (02) : 131 - 141
  • [4] BALTZ RH, 1988, ANNU REV MICROBIOL, V42, P547
  • [5] BOECKMAN RK, 1988, TOTAL SYNTHESIS NATU, P102
  • [6] MACROLIDE BIOSYNTHESIS .4. INTACT INCORPORATION OF A CHAIN-ELONGATION INTERMEDIATE INTO ERYTHROMYCIN
    CANE, DE
    YANG, CC
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1987, 109 (04) : 1255 - 1257
  • [7] THE USE OF RECOMBINANT-DNA TECHNIQUES TO STUDY TYLOSIN BIOSYNTHESIS AND RESISTANCE IN STREPTOMYCES-FRADIAE
    COX, KL
    FISHMAN, SE
    LARSON, JL
    STANZAK, R
    REYNOLDS, PA
    YEH, WK
    VANFRANK, RM
    BIRMINGHAM, VA
    HERSHBERGER, CL
    SENO, ET
    [J]. JOURNAL OF NATURAL PRODUCTS, 1986, 49 (06): : 971 - 980
  • [8] CLONING GENES FOR THE BIOSYNTHESIS OF A MACROLIDE ANTIBIOTIC
    FISHMAN, SE
    COX, K
    LARSON, JL
    REYNOLDS, PA
    SENO, ET
    YEH, WK
    VANFRANK, R
    HERSHBERGER, CL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) : 8248 - 8252
  • [9] NOVEL FERMENTATION PRODUCTS FROM STREPTOMYCES-FRADIAE - X-RAY CRYSTAL-STRUCTURE OF 5-O-MYCAROSYLTYLACTONE AND PROOF OF THE ABSOLUTE-CONFIGURATION OF TYLOSIN
    JONES, ND
    CHANEY, MO
    KIRST, HA
    WILD, GM
    BALTZ, RH
    HAMILL, RL
    PASCHAL, JW
    [J]. JOURNAL OF ANTIBIOTICS, 1982, 35 (04) : 420 - 425
  • [10] MACROLIDE SYNTHESIS - NARBONOLIDE
    KAIHO, T
    MASAMUNE, S
    TOYODA, T
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1982, 47 (08) : 1612 - 1614